Theranostic potential of oncolytic vaccinia virus

Area of Science:

• Oncology
• Virology
• Medical Imaging

Background:

• Biological cancer therapies, like oncolytic viruses, offer multi-mechanism advantages over traditional treatments.
• Rapid clinical development of these viruses presents complex pre-clinical and clinical study challenges.
• Defining treatment failure and enhancement strategies for oncolytic viruses is complicated by numerous parameters.

Purpose of the Study:

• To review reporter genes and imaging modalities for non-invasive in vivo imaging of viral gene expression in oncolytic virus therapy.
• To discuss applications of this imaging in pre-clinical and clinical studies of oncolytic viruses.
• To explore future uses in tumor phenotyping and personalized treatment regimens.

Main Methods:

• Review of various reporter genes used with oncolytic viruses.
• Description of imaging modalities for measuring reporter gene expression.
• Discussion of applications in pre-clinical and clinical settings.

Main Results:

• Non-invasive imaging of viral gene expression significantly enhances oncolytic virus development speed and data quality.
• Imaging can potentially predict response to oncolytic viral therapy before changes in tumor burden.
• Reporter gene expression holds promise for tumor phenotyping and personalized treatment.

Conclusions:

• Non-invasive imaging of viral gene expression is crucial for advancing oncolytic virus therapy.
• This technology facilitates complex study designs and aids in treatment optimization.
• Future applications include personalized medicine approaches in cancer treatment.